[HTML][HTML] Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy

A Pal, R Kundu - Frontiers in microbiology, 2020 - frontiersin.org
Human papillomavirus (HPV)-induced cervical cancer is a major health issue among
women from the poorly/under-developed sectors of the world. It accounts for a high-mortality …

[HTML][HTML] Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy

M Canning, G Guo, M Yu, C Myint… - Frontiers in cell and …, 2019 - frontiersin.org
Head and neck squamous cell carcinomas (HNSCCs) are highly aggressive, multi-factorial
tumors in the upper aerodigestive tract affecting more than half a million patients worldwide …

[HTML][HTML] Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies

R Bhattacharjee, SS Das, SS Biswal, A Nath… - Critical reviews in …, 2022 - Elsevier
Purpose Cervical cancer (CC), one of the major causes of death of women throughout the
world is primarily caused due to Human Papilloma Virus (HPV) 16 and 18. The early region …

[HTML][HTML] The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications

P Economopoulou, C Perisanidis… - Annals of …, 2016 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, with low
survival rates for advanced stage tumors and minimal improvement in survival trends …

Precision medicine in head and neck cancer

O Kaidar-Person, Z Gil, S Billan - Drug Resistance Updates, 2018 - Elsevier
Head and Neck cancer is among the most common cancers worldwide, with a high
prevalence in south East Asia, Brazil and central Europe. Head and Neck Squamous cell …

Immunotherapy targeting HPV16/18 generates potent immune responses in HPV-associated head and neck cancer

C Aggarwal, RB Cohen, MP Morrow, KA Kraynyak… - Clinical Cancer …, 2019 - AACR
Purpose: Clinical responses with programmed death (PD-1) receptor–directed antibodies
occur in about 20% of patients with advanced head and neck squamous cell cancer …

[HTML][HTML] The promise of immunotherapy in head and neck squamous cell carcinoma

P Economopoulou, S Agelaki, C Perisanidis… - Annals of …, 2016 - Elsevier
Squamous cell cancers of the head and neck (HNSCC) comprise a diverse group of
malignancies that includes tobacco-related tumors in addition to an increasing number of …

Immunotherapy for head and neck cancer

F Sim, R Leidner, RB Bell - Oral and …, 2019 - oralmaxsurgery.theclinics.com
Advances in immunotherapy have transformed the practice of oncology. Immunotherapy for
treatment of cancer relies on the principle that tumors are recognized as foreign by the host …

Immunotherapy advances in locally advanced and recurrent/metastatic head and neck squamous cell carcinoma and its relationship with human papillomavirus

H Wang, Q Zhao, Y Zhang, Q Zhang, Z Zheng… - Frontiers in …, 2021 - frontiersin.org
Head and neck cancer (HNC) is the sixth most common malignancy worldwide; head and
neck squamous cell carcinoma (HNSCC) account for the most cases of HNC. Past smoking …

The role of immune modulatory cytokines in the tumor microenvironments of head and neck squamous cell carcinomas

N Kondoh, M Mizuno-Kamiya - Cancers, 2022 - mdpi.com
Simple Summary Malignant phenotypes of head and neck squamous cell carcinomas
(HNSCCs) are regulated by the pro-and anti-tumoral activities of immune modulatory …